Inactive Instrument
AS Olainfarm Share Price Deutsche Boerse AG
Stocks
UU4
LV0000100501
Pharmaceuticals
| 07/01/22 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/01/22 | Notification about results of final buy-back of shares | AQ |
| 30/12/21 | Notification about final share buy-back | AQ |
| 28/12/21 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/12/21 | On substantial participation (4) - specified | AQ |
| 1 day | -0.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 31/12/2025 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 31/12/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 18/06/2021 | |
Janis Buks
CHM | Chairman | - | 31/08/2022 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.24% | -3.46% | - | - | 148M | |
| +0.14% | +1.70% | +23.42% | +74.18% | 48.77B | |
| +1.44% | +1.27% | +53.88% | +120.98% | 40.67B | |
| -1.16% | +0.37% | +15.87% | +88.00% | 12.27B | |
| -0.72% | +0.72% | -9.97% | +13.44% | 12.11B | |
| +0.57% | +0.95% | +29.02% | +153.11% | 9.28B | |
| -2.36% | -3.76% | +23.20% | +42.78% | 7.55B | |
| -0.42% | +0.89% | +28.21% | +224.95% | 7.35B | |
| +0.32% | +0.83% | +43.52% | -11.03% | 7.3B | |
| -1.29% | -1.78% | -40.82% | +14.36% | 5.25B | |
| Average | -0.40% | +0.79% | +18.48% | +80.08% | 16.73B | |
| Weighted average by Cap. | +0.08% | +1.17% | +27.64% | +87.49% |
Employees
2,191
Sector
Pharmaceuticals
